Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

India flag India · Delayed Price · Currency is INR
222.00
+2.00 (0.91%)
At close: Feb 12, 2026
Market Cap2.27B +55.7%
Revenue (ttm)979.90M +8.8%
Net Income82.09M +102.6%
EPS7.76 +229.3%
Shares Out10.52M
PE Ratio27.83
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,800
Average Volume6,440
Open222.25
Previous Close220.00
Day's Range222.00 - 224.40
52-Week Range81.10 - 335.00
Beta0.01
RSI30.33
Earnings DateFeb 4, 2026

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health su... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1999
Employees 636
Stock Exchange National Stock Exchange of India
Ticker Symbol MADHAVBAUG
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:MADHAVBAUG's revenue was 898.47 million, a decrease of -9.55% compared to the previous year's 993.31 million. Earnings were 71.36 million, an increase of 260.34%.

Financial Statements